Alyeska Investment Group’s LianBio American Depositary Shares LIAN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-429,186
Closed -$858K 531
2022
Q3
$858K Buy
429,186
+100,000
+30% +$239K 0.01% 346
2022
Q2
$711K Sell
329,186
-10,056
-3% -$34.1K 0.01% 513
2022
Q1
$1.26M Buy
339,242
+54,392
+19% +$225K 0.01% 478
2021
Q4
$1.75M Buy
+284,850
New +$3.25M 0.02% 460

Other funds holding LIAN

Alyeska Investment Group's LIAN Position: Q4 2022 in Review

Alyeska Investment Group sold out of LianBio American Depositary Shares (LIAN) in Q4 2022, closing a stake of 429,186 shares — an estimated $858K sold.

Alyeska Investment Group first reported a position in LIAN in Q4 2021 and held it in 4 quarters. The position peaked at $1.75M in Q4 2021. 40 funds tracked by Wall St. Rank hold LIAN as of Q4 2022.

  • Alyeska Investment Group reported no remaining LianBio American Depositary Shares position as of Q4 2022 after selling out during the quarter.
  • Alyeska Investment Group sold 429,186 LianBio American Depositary Shares shares in Q4 2022, an estimated $858K.
  • Alyeska Investment Group first reported a position in LianBio American Depositary Shares in Q4 2021 and held it in 4 quarters.
  • Alyeska Investment Group's LianBio American Depositary Shares position peaked at $1.75M in Q4 2021.
  • 40 funds tracked by Wall St. Rank held LianBio American Depositary Shares as of Q4 2022.

Based on Alyeska Investment Group's 13F filing for Q4 2022, filed 14 Feb 2023.